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Abstract
Various wheezing phenotypes can be identified based on differences in natural histories, risk factors and responses 
to treatment. In epidemiologic studies, atopic asthma or virus-induced wheezing can be discriminated by the 
presence or the absence of sensitization to allergens. Children with asthma have been shown to present lower levels 
of lung function. Patients with viral respiratory infections evolve from normal lung function to enhanced airway 
reactivity. The objective of this study was to identify genes and polymorphisms associated with different wheezing 
phenotypes. Using data obtained from the Genetic Association Database, we systematically reviewed studies on 
genes and polymorphisms that have been associated with virus-induced wheezing or atopic asthma. The research 
was carried out in February of 2009. Genes associated with the studied outcomes in more than three studies were 
included in the analysis. We found that different genes and loci have been associated with virus-induced wheezing 
or atopic asthma. Virus-induced wheezing has frequently been associated with IL-8 polymorphisms, whereas atopic 
asthma and atopy have frequently been associated with Th2 cytokine gene (CD14 and IL-13) polymorphisms on 
chromosome 5. This review provides evidence that different wheezing disorders in childhood can be differently 
affected by genetic variations, considering their role on airway inflammation and atopy. Future studies of genetic 
associations should consider the different wheezing phenotypes in infancy. In addition, stratified analyses for atopy 
can be useful for elucidating the mechanisms of the disease. 
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Resumo
Diversos fenótipos de sibilância têm sido identificados com base em diferenças na história natural, fatores de risco 
e resposta ao tratamento. Em estudos epidemiológicos, a asma atópica ou sibilância induzida por vírus pode ser 
discriminada pela presença ou ausência de sensibilização a alérgenos. As crianças com asma apresentam níveis 
menores de função pulmonar. Pacientes com infecções respiratórias virais apresentam-se com função pulmonar 
normal, mas mostram reatividade da via aérea aumentada. O objetivo deste trabalho foi identificar genes e poli-
morfismos associados aos diferentes fenótipos de sibilância. Utilizando dados do Genetic Association Database, foi 
realizada uma revisão sistemática de estudos sobre genes e polimorfismos associados à sibilância induzida por vírus 
ou à asma atópica. O levantamento foi realizado em fevereiro de 2009. Todos os genes associados com o desfecho 
estudado presentes em mais de três estudos foram incluídos na análise. Identificamos que diferentes genes e locos 
têm sido associados à sibilância induzida por vírus ou à asma atópica. Enquanto a sibilância induzida por vírus foi 
mais frequentemente associada a polimorfismos no gene IL-8, polimorfismos localizados em genes de citocinas 
Th2 no cromossomo 5 (CD14 e IL-13) foram frequentemente associados à atopia ou à asma atópica. Esta revisão 
mostrou evidências de que a sibilância na infância pode ser afetada por variações genéticas de formas diferentes, 
dependendo de seu papel na inflamação das vias aéreas e na atopia. Estudos futuros de associação genética 
deverão levar em consideração os diferentes fenótipos na infância. Além disso, análises estratificadas para atopia 
podem ser úteis para elucidar os mecanismos da doença. 
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atopy is associated with asthma symptoms that 
start early in life and persist into adulthood.
Lower respiratory illnesses (LRIs) caused 
by viral infection can also be associated with 
persistent wheezing in infants and preschool 
children. Non-atopic wheezers evolve from 
normal lung function to slightly impaired lung 
function and enhanced airway reactivity later in 
childhood. Stein et al.(15) examined the relation-
ship between LRIs in infants and the subsequent 
development of wheezing during the first 
decade of life. The authors found that most 
wheezing episodes are due to viral respiratory 
infections, with respiratory syncytial virus (RSV) 
being detected in the majority of these episodes. 
Analyses demonstrated that RSV infections 
in infancy were associated with an increased 
risk of wheezing during the first ten years of 
life, regardless of other known risk factors for 
asthma or asthma-related symptoms, such as 
family history of asthma or atopy. However, 
RSV-induced wheezing has not been associated 
with an increased risk of atopy or higher serum 
IgE levels.
Children who had virus-induced wheezing 
early in life were more likely to have lower 
levels of lung function at eleven years of age 
when compared with controls. One can suggest 
that, in some children, the viral infection led to 
a specific inflammatory response that caused 
this long-term airway obstruction. Therefore, 
a significant number of children who present 
wheezing during the first decade of life do so in 
association with viral respiratory agents regard-
less of atopy. This wheezing phenotype seems to 
be associated with wheezing that is less severe. 
Among school-age children in developed coun-
tries, this phenotype is probably less prevalent 
than is the atopic phenotype, although this 
might not hold true in different environments. 
Findings from developing countries(16) have led 
to the hypothesis that different risk factors, 
such as recurrent or severe viral aggressions, are 
associated with an increased expression of this 
wheezing phenotype that is not associated with 
atopy. Genetic variants in the genes associated 
with the immune response can be associated 
with either non-atopic forms of wheezing or 
atopic asthma. Unless the atopic and non-atopic 
forms of wheezing are analyzed separately, the 
effects might not be detected.
Introduction
Although wheezing is highly prevalent in 
infants and children in the first six years of life, 
only certain children develop persistent atopic 
asthma later in life.(1) Diverse wheezing pheno-
types can be identified based on differences in 
risk factors, natural histories and responses to 
treatment.(2-3) International guidelines, which 
are based on the efficacy of systemic corticos-
teroids in reducing hospitalization in children 
with classic atopic asthma, recommend the use 
of oral corticosteroids for children with virus-
induced wheezing who present to a hospital. 
However, the results of trials that have addressed 
the question of efficacy of systemic corticoster-
oids in young children with acute wheezing are 
contradictory. Atopic wheezing and non-atopic 
wheezing have contrasting natural histories and 
can have different etiologies. Atopic asthma has 
been associated with an allergic or eosinophilic 
response in older patients with asthma.(4) 
However, in young children with virus-induced 
wheezing, neutrophils typically predominate in 
BAL fluid samples.(5)
In various epidemiologic studies,(6-7) children 
with atopic asthma have been shown to present 
positive skin prick test results and increased 
airway responsiveness as major associated risk 
factors. Among such children, there is a signifi-
cant association between an early onset of 
wheezing and the severity of the disease. Children 
with atopy have been shown to present lower 
levels of lung function by three years of age.
(8) For preschool children with wheezing, early 
allergic sensitization increases the prevalence of 
respiratory symptoms, airway inflammation and 
the risk of asthma being diagnosed later in life. 
Several studies have shown that asthma during 
childhood is strongly associated with elevated 
serum IgE and positive skin prick test results.(9-11) 
Early sensitization to allergens is associated with 
an increased risk for the development of bron-
chial hyperresponsiveness.(12) Elevated IgE levels 
at nine months of age correlates directly with the 
risk of persistent wheezing, suggesting a form of 
IgE-mediated sensitization during the first years 
of life.(13) Children who had asthma by seven 
years of age were sensitized very early in life and 
had persistent sensitization when compared with 
children who did not have asthma.(14) These find-
ings indicate that a genetic predisposition for 
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mosome 16 (IL-4R) were associated with atopy 
or atopic asthma in 16 studies (CD14 in 5, IL-13 
in 4 and IL-4R in 7, Chart 2).
Studies on Th2 cytokines and their rela-
tionship with asthma have focused on IL-4 
and IL-13. This is due to the crucial role of 
these two cytokines in the generation of Th2 
responses: IL-4 is essential for the matura-
tion of naive T cells towards Th2 cells and 
the production of IgE; and IL-13 is a protein 
product that shares several biological profiles 
with IL-4, including IgE production and MHC 
class II expression.(18-21) However, IL-8 is a chem-
okine that has been associated preferentially 
with virus-induced inflammation and is one 
of the major  mediators of the inflammatory 
response. It is secreted by several cell types and 
functions as a chemoattractant factor, especially 
for neutrophils. In addition, IL-8 is believed to 
play a role in the pathogenesis of bronchiolitis, 
a common respiratory tract disease in infants 
caused by viral infections.(22,23) Considering these 
data, IL-8 and other members of the chemokine 
gene family can be considered relevant candi-
date genes for non-atopic forms of wheezing in 
childhood.
Genetics of atopic asthma
Studies of twins have shown the importance 
of the genetics in asthma variance, with esti-
mated heritability ranging from 48% to 79%. 
One important finding is that most of these twin 
studies in different parts of the developed world 
showed similar and consistent results and suggest 
that atopic asthma, in particular, has a strong 
genetic background. Although we can estimate 
to what extent genetic susceptibility contributes 
to the risk of asthma and atopy, all specific loci 
that influence this clinical phenotype are far from 
being clearly determined. Although a signifi-
cant number of genetic association studies have 
described atopy susceptibility genes, these data 
Data collection
The Genetic Association Database (GAD) is 
an archive of human genetic association studies 
of complex disorders, organized by the National 
Institute of Health (http://geneticassociationdb.
nih.gov/). This database allows researchers to 
identify relevant polymorphisms from the large 
volume of gene variations, in the context of 
a standardized nomenclature for genes and 
polymorphisms. The database includes selected 
published scientific papers. Study data are 
recorded with the official nomenclature used 
for the human genome. The submitted records 
are reviewed before their inclusion in the data-
base.(17) In the present study, we searched the 
GAD, employing the following search terms: 
“virus and asthma”; “respiratory syncytial virus”; 
“asthma and atopy”; and “atopy”. All searches 
were performed in February of 2009. Genes that 
were associated with the studied outcomes in 
more than three studies were included in the 
analysis.
Genetic associations with atopic  
asthma and virus-induced asthma
The number of studies identified for each 
term was the following: 2 for “virus and 
asthma”; 15 for “respiratory syncytial virus”; 
9 for “asthma and atopy”; and 79 for “atopy”. 
The 9 studies related to asthma and atopy 
were grouped together with those related to 
atopy alone. In addition, the 2 papers related to 
virus and asthma were grouped together with 
those related to RSV. Genes that were associ-
ated with the studied outcomes in more than 
three studies were further reviewed. Viral or 
specifically RSV-induced wheezing was associ-
ated with polymorphisms in IL-8 in 4 different 
studies (Chart 1). Single nucleotide polymor-
phisms (SNPs) located on Th2 genes positioned 
on chromosome 5 (CD14 and IL-13) and chro-
Chart 1 - Genes associated with virus-induced wheezing in more than three genetic studies.
Gene Phenotype Chr Chr and band Reference
IL-8 RSV-induced wheezing 4 4q13-q21 Hull et al.(32)
IL-8 RSV-induced wheezing 4 4q13-q21 Puthothu et al.(34)
IL-8 RSV-induced wheezing 4 4q13-q21 Heinzmann et al.(31)
IL-8 RSV infection 4 4q13-q21 Lu et al.(35)
Chr: chromossome; and RSV: respiratory syncytial virus.
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coding SNP of IL-13 (rs20541) is associated with 
asthma in case-control populations; the variant 
also predicted asthma and higher serum IL-13 
levels in a Japanese population. The protein 
encoded by the IL-4 gene is a Th2 cytokine 
produced by activated T cells that influence the 
allergic immune response. The IL-4 receptor also 
binds to IL-13, which might contribute to over-
lapping functions of IL-4 and IL-13. It has also 
been suggested that SNPs in the IL-4 gene are 
involved in the development of asthma and the 
regulation of total serum IgE.(20) Our group has 
shown(21) that the combined analyses of genetic 
alterations in the IL-4/IL-13 pathway reveal 
their significance for the development of atopy 
and childhood asthma. Moreover, other genes 
harbored at the same loci, such as CD14, might 
contribute to asthma and allergy.
The IL-4 receptor (IL-4R), on chromosome 
16p, is a key component in the induction of Th2 
lymphocytes. A further role that IL-4 plays in the 
pathogenesis of asthma has been indicated from 
sensitized il-4 knockout mice. Neither specific 
IgE induction nor bronchial hyperreactivity was 
detected in these mice, suggesting a critical role 
for the IL-4/IL-4R pathway in these pheno-
types. At least 16 SNPs in the IL-4RA gene have 
been reported. The coding polymorphisms I50V, 
S478P, and Q551R have been associated with 
a greater risk of atopy, a greater risk of atopic 
asthma, and variations in IgE levels.(18)
demonstrate the extreme complexity of the trait, 
and the identification of these polymorphisms 
presents a considerable challenge.
Several candidate genes have been studied 
in atopic disorders, and different factors 
contribute to this abundance of candidates. 
Results from genome screens have provided 
evidence of linkage to multiple sites in the 
genome. Therefore, there are candidate genes 
at many positions. In addition, immunological 
pathways associated with the allergic response 
involve a large array of inflammatory mediators. 
However, the best replicated results in genetic 
association studies of atopic asthma involve the 
human genome regions 5q31-32 and 16p11-12 
(Chart 2).
There is evidence that Th2 genes located 
on chromosome 5q (IL-13 and IL-4) are major 
determinants of atopic asthma. In addition, 
IL-13 encodes an immunoregulatory cytokine 
produced primarily by activated Th2 cells, and 
this cytokine promotes IgE isotype switching. 
Furthermore, IL-13 inhibits the production of 
pro-inflammatory chemokines. This cytokine 
is found to be critical to the pathogenesis of 
allergen-induced asthma. The IL-13 and IL-4 
genes form a cytokine gene cluster on chro-
mosome 5q. It has been reported that the 
promoter SNP rs1800925 of the IL-13 gene 
contributes significantly to bronchial hyper-
responsiveness and susceptibility to atopic 
asthma.(18) Heinzmann et al.(19) determined that a 
Chart 2 - Genes associated with atopic asthma or atopy in more than three genetic studies.
Gene Phenotype Chr Chr and band Reference
CD14 Atopy (total IgE)) 5 5q22-q32 Leung et al.(36)
CD14 Atopy 5 5q22-q32 Buckova et al.(37)
CD14 Atopy 5 5q22-q32 Kabesch et al.(38)
CD14 Atopy 5 5q22-q32 Leynaert et al.(39)
CD14 Atopy 5 5q22-q32 Koppleman et al.(40)
IL-13 Atopy 5 5q31 Liu et al.(41)
IL-13 Atopy (specific IgE) 5 5q31 Leung et al.(42)
IL-13 Asthma and atopy 5 5q31 Howard et al.(43)
IL-13 Atopy 5 5q31 Nieters et al(44)
IL-4R Atopy 16 16p11-12 Ober et al(45)
IL-4R Atopy 16 16p11 Liu et al.(41)
IL-4R Atopy (IgE) 16 16p11 Heinzmann et al.(19)
IL-4R Atopy 16 16p11 Nieters et al.(44)
IL-4R Atopy 16 16p11 Deichmann et al.(46)
IL-4R Atopic asthma 16 16p11 Isidoro-Garcia et al.(47)
IL-4R Asthma and atopy 16 16p11 Kruse et al.(48)
Chr: chromossome; and IL-4R: IL-4 receptor.
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of the disease. The effect was most marked for 
severe disease requiring oxygen therapy for more 
than two days, and for cases of bronchiolitis 
with no other known risk factors.
Final considerations
This review demonstrated different effects of 
genetic variations in atopic(36-48) and non-atopic 
wheezing.(31-35) These differences should be 
interpreted considering the role of these genes 
on airway inflammation and atopy. Although 
these phenotypes can have different etiologies, 
no clinical index or test for the differentiation 
between atopic asthma and viral wheezing has 
proven sufficiently accurate to be useful in 
young children. However, future genetic associa-
tion studies should systematically investigate the 
wheezing phenotypes separately. Such studies 
could identify clinical relevant genetic markers 
of virus-induced wheezing or atopic asthma.
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